#Moderna
-
IDNA ETF Surges as Moderna Trial Data Adds Nearly 12 NAV Points
The iShares Genomics Immunology and Healthcare ETF was reshaped by a single clinical catalyst after Moderna and Merck rallied sharply…
-
Moderna Stock Soars 93% After Phase 3 Melanoma Trial Win
Moderna shares nearly doubled after a positive Phase 3 readout for its personalized melanoma therapy with Merck. The rally added…
-
Moderna Ebola Vaccine Deal: CEPI Commits Up to $50 Million
Moderna has secured up to $50 million from CEPI to accelerate development of an Ebola vaccine as infections rise in…